1. Source WHO-Global Surveillance System: http://www.who.int/m/topics/hepatitis/en/index.html
2. Source Onusida/WHO (2003)
3. Rockstroh J, Konopnicki DV, Soriano VO, et al. (2004) Hepatitis B and hepatitis C in the EuroSIDA cohort: prevalence and effect on mortality, AIDS progression and response to HAART. Program and abstracts of the 11th Conference on retroviruses and opportunistic infection, San Francisco CA (Abstract 799)
4. Bica I, McGovern B, Dhar R, et al. (2001) Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 132(3): 492–497
5. Ouattara SA, Meite M, Aron Y, et al. (1990) Increase of the prevalence of hepatitis B virus surface antigen related to immunodeficiency inherent in acquired immune deficiency syndrome (AIDS). J Acquir Immune Defic Syndr 3(3): 282–286